Ergoteles LLC Amgen Inc Transaction History

Ergoteles LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $249,497 - $304,096	-1,105 Reduced 8.66%	11,658 $2.82 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $345,835 - $439,425	1,510 Added 13.42%	12,763 $3.35 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.37 Million - $1.54 Million	6,097 Added 118.25%	11,253 $2.54 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $980,517 - $1.09 Million	4,250 Added 469.09%	5,156 $1.25 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $198,658 - $219,768	906 New	906 $219,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $11 Million - $12.9 Million	-51,697 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $12.1 Million - $13.4 Million	51,697 New	51,697 $12.6 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $813,965 - $948,544	-3,668 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $4.57 Million - $5.45 Million	-21,132 Reduced 85.21%	3,668 $843,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $5.82 Million - $6.47 Million	24,800 New	24,800 $6.3 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $139B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.